AU4473497A - Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome - Google Patents

Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome

Info

Publication number
AU4473497A
AU4473497A AU44734/97A AU4473497A AU4473497A AU 4473497 A AU4473497 A AU 4473497A AU 44734/97 A AU44734/97 A AU 44734/97A AU 4473497 A AU4473497 A AU 4473497A AU 4473497 A AU4473497 A AU 4473497A
Authority
AU
Australia
Prior art keywords
vaccine
coli
transformed
recombinant plasmid
diagnostic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44734/97A
Inventor
Kuen Taik Chung
Hyun Su Kim
Jong Wan Kim
Soo Ok Kim
Sang Bum Moon
Kap Soo Noh
Young Chul Shin
Wang Don Yoo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CJ Corp
Original Assignee
CJ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019970038168A external-priority patent/KR19980032276A/en
Application filed by CJ Corp filed Critical CJ Corp
Publication of AU4473497A publication Critical patent/AU4473497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/12011—Bunyaviridae
    • C12N2760/12111—Hantavirus, e.g. Hantaan virus
    • C12N2760/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU44734/97A 1996-10-04 1997-10-02 Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome Abandoned AU4473497A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
KR19960044666 1996-10-04
KR9644666 1996-10-04
KR19960077034 1996-12-30
KR9677034 1996-12-30
KR1019970038168A KR19980032276A (en) 1996-10-04 1997-08-06 Nucleocapsid Protein Gene, Recombinant Plasmid, Transgenic E. Coli, and Nephrotic Syndrome Hemorrhagic Fever Diagnostics and Preventive Vaccines of Seoul Virus R22
KR9738168 1997-08-06
PCT/KR1997/000184 WO1998014585A1 (en) 1996-10-04 1997-10-02 Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome

Publications (1)

Publication Number Publication Date
AU4473497A true AU4473497A (en) 1998-04-24

Family

ID=27349401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44734/97A Abandoned AU4473497A (en) 1996-10-04 1997-10-02 Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome

Country Status (2)

Country Link
AU (1) AU4473497A (en)
WO (1) WO1998014585A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI980889A1 (en) * 1998-04-24 1999-10-24 Diesse Diagnostica RECOMBINANT NUCLEOPROTEIN OF THE TUSCAN VIRUS
DE60006146T2 (en) 1999-11-04 2004-09-30 Exxonmobil Chemical Patents Inc., Baytown PROPYLENE COPOLYMER FOAMS AND THEIR USE
AU780051B2 (en) 1999-12-21 2005-02-24 Exxonmobil Chemical Patents Inc Adhesive alpha-olefin inter-polymers
WO2020056119A1 (en) 2018-09-14 2020-03-19 Fina Technology, Inc. Polyethylene and controlled rheology polypropylene polymer blends and methods of use
MX2021006769A (en) 2019-02-20 2021-07-15 Fina Technology Polymer compositions with low warpage.
GB201910804D0 (en) * 2019-07-29 2019-09-11 Secetary Of State For Health And Socail Care Hantavirus antigenic Composition
CA3214562A1 (en) 2021-04-26 2022-11-03 Michael Mcleod Thin single-site catalyzed polymer sheets

Also Published As

Publication number Publication date
WO1998014585A1 (en) 1998-04-09

Similar Documents

Publication Publication Date Title
FR2712603B1 (en) Recombinant viruses, preparation and use in gene therapy.
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
WO2000000616A3 (en) Marburg virus vaccines
WO1998013501A3 (en) 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
FR2716893B1 (en) Recombinant viruses, their preparation and their therapeutic use.
CA2118816A1 (en) Composition for introducing nucleic acid complexes into higher eucaryotic cells
AU1436401A (en) RepO-associated virus AAV REP78 major regulatory protein, mutants thereof and uses thereof
HUP9900389A3 (en) Mixture of recombinant viruses as polyenv vaccines for hiv, preparation and use thereof
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
FR2718150B1 (en) Recombinant viruses, preparation and use in gene therapy.
CA2005950A1 (en) Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
AU3764899A (en) High molecular weight polyols, process for preparation and use thereof
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
WO1998013500A3 (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
AU3431297A (en) Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
AU1632392A (en) Recombinant avipox virus, the culture of cells infected with this virus and vaccines for poultry derived from this virus
AU2657100A (en) Cotton leaf curl virus (clcuv) promoter and its use
AU1927797A (en) Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines
AU4473497A (en) Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome
EP0806203A3 (en) Anti-viral compositions
EP0811600A3 (en) Anti-viral compounds
EP0811599A3 (en) Anti-viral compounds
GB2376687A (en) Herpes viruses for immune modulation
WO1997041822A3 (en) Anti-viral compounds
EP0806410A3 (en) Anti-viral compounds